作者:Matthew J. Fisher、Ryan T. Backer、Vanessa N. Barth、Kim E. Garbison、Joseph M. Gruber、Beverly A. Heinz、Smriti Iyengar、Sean P. Hollinshead、Anne Kingston、Steven L. Kuklish、Linglin Li、Eric S. Nisenbaum、Steven C. Peters、Lee Phebus、Rosa Maria A. Simmons、Ellen van der Aar
DOI:10.1016/j.bmcl.2012.02.003
日期:2012.4
The disclosed 3-phenyl-5-isothiazole carboxamides are potent allosteric antagonists of mGluR1 with generally good selectivity relative to the related group 1 receptor mGluR5. Pharmacokinetic properties of a member of this series (1R,2R)-N-(3-(4-methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropanecarboxamide (14) are good, showing acceptable plasma and brain exposure after oral dosing. Oral administration of isothiazole 14 gave robust activity in the formalin model of persistent pain which correlated with CNS receptor occupancy. (C) 2012 Elsevier Ltd. All rights reserved.